Literature DB >> 11709646

Vagus nerve stimulation, side effects, and long-term safety.

E Ben-Menachem1.   

Abstract

Vagus nerve stimulation (VNS) is an accepted therapy for the treatment of refractory epilepsy and now even depression. More than 10,000 people have had the device implanted over a period of 12 years. Initial side effects in the early years such as lower facial weakness and electrode lead breaks have now been resolved. Postoperative infections occur in approximately 3% of patients but can be treated with oral antibiotics. Side effects during the use of VNS are usually related to the "on" phase of stimulation. Common side effects are cough, hoarseness, voice alteration, and paresthesias. These side effects tend to diminish with time. Cognitive side effects often seen with antiepileptic drug use are not reported. The side effect profile of VNS is positive, and this treatment option offers patients with refractory epilepsy prospects of good efficacy with only minor and often resolvable side effects.

Entities:  

Mesh:

Year:  2001        PMID: 11709646     DOI: 10.1097/00004691-200109000-00005

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  64 in total

Review 1.  Neurostimulation therapy for epilepsy.

Authors:  Douglas Labar; Andy Dean
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

2.  Early seizure detection in rats based on vagus nerve activity.

Authors:  Kristian R Harreby; Cristian Sevcencu; Johannes J Struijk
Journal:  Med Biol Eng Comput       Date:  2010-10-02       Impact factor: 2.602

3.  Electroceutical Targeting of the Autonomic Nervous System.

Authors:  Charles C Horn; Jeffrey L Ardell; Lee E Fisher
Journal:  Physiology (Bethesda)       Date:  2019-03-01

Review 4.  New approaches for treating atrial fibrillation: Focus on autonomic modulation.

Authors:  Daniel Sohinki; Stavros Stavrakis
Journal:  Trends Cardiovasc Med       Date:  2019-10-31       Impact factor: 6.677

Review 5.  Brain stimulation in obesity.

Authors:  C H Göbel; V M Tronnier; T F Münte
Journal:  Int J Obes (Lond)       Date:  2017-08-01       Impact factor: 5.095

Review 6.  Vagal stimulation in heart failure.

Authors:  Gaetano M De Ferrari
Journal:  J Cardiovasc Transl Res       Date:  2014-02-06       Impact factor: 4.132

Review 7.  Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics.

Authors:  Kalyanam Shivkumar; Olujimi A Ajijola; Inder Anand; J Andrew Armour; Peng-Sheng Chen; Murray Esler; Gaetano M De Ferrari; Michael C Fishbein; Jeffrey J Goldberger; Ronald M Harper; Michael J Joyner; Sahib S Khalsa; Rajesh Kumar; Richard Lane; Aman Mahajan; Sunny Po; Peter J Schwartz; Virend K Somers; Miguel Valderrabano; Marmar Vaseghi; Douglas P Zipes
Journal:  J Physiol       Date:  2016-06-14       Impact factor: 5.182

8.  Optimization of the electrode drive pattern for imaging fascicular compound action potentials in peripheral nerve with fast neural electrical impedance tomography.

Authors:  Enrico Ravagli; Svetlana Mastitskaya; Nicole Thompson; Kirill Aristovich; David Holder
Journal:  Physiol Meas       Date:  2019-12-03       Impact factor: 2.833

9.  Vagus Nerve Stimulation As Treatment for Epileptic Seizures.

Authors:  Martin C. Salinsky
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

10.  N-terminal pro-brain natriuretic peptide (NT-proBNP) release in children with vagus nerve stimulation. A prospective case series.

Authors:  Markus Rauchenzauner; Edda Haberlandt; Martin Ortler; Tobias Tatarczyk; Markus Laimer; Eugen Trinka; Gerhard Luef
Journal:  J Neurol       Date:  2008-06-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.